MINNEAPOLIS, Aug. 15, 2011 (GLOBE NEWSWIRE) -- PuraMed BioSciences, Inc. (OTCQB:PMBS) has chosen Media Relations, Inc. to create consumer awareness and excitement nationally for LipiGesic M, the company's new non-prescription migraine treatment, which independent clinical research has shown to be a highly effective first-line therapy for migraines.
